Abstract:Cytochrome P450 3A4 (CYP3A4), a key enzyme, is pivotal in metabolizing approximately half of the drugs used clinically. The genetic polymorphism of the CYP3A4 gene significantly influences individual variations in drug metabolism, potentially leading to severe adverse drug reactions (ADRs). In this study, we conducted a genetic analysis on CYP3A4 gene in 1163 Chinese Han individuals to identify the genetic variations that might affect their drug metabolism capabilities. For this purpose, a multiplex polymerase chain reaction (PCR) amplicon sequencing technique was developed, enabling us to perform the genotyping of CYP3A4 gene efficiently and economically on a large scale. As a result, a total of 14 CYP3A4 allelic variants were identified, comprising six previously reported alleles and eight new nonsynonymous variants that were nominated as new allelic variants *39–*46 by the PharmVar Association. Further, functional assessments of these novel CYP3A4 variants were undertaken by coexpressing them with cytochromes P450 oxidoreductase (CYPOR) in Saccharomyces cerevisiae microsomes. Immunoblot analysis indicated that with the exception of CYP3A4.40 and CYP3A4.45, the protein expression levels of most new variants were similar to that of the wild-type CYP3A4.1 in yeast cells. To evaluate their catalytic activities, midazolam was used as a probe drug. The results showed that variant CYP3A4.45 had almost no catalytic activity, whereas the other variants exhibited significantly reduced drug metabolism abilities. This suggests that the majority of the CYP3A4 variants identified in the Chinese population possess markedly altered capacities for drug metabolism. SIGNIFICANCE STATEMENT In this study, we established a multiplex polymerase chain reaction (PCR) amplicon sequencing method and detected the maximum number of new CYP3A4 variants in a single ethnic population. Additionally, we performed the functional characterizations of these eight novel CYP3A4 allele variants in vitro. This study not only contributes to the understanding of CYP3A4 genetic polymorphism in the Chinese Han population but also holds substantial reference value for their potential clinical applications in personalized medicine.

Discovery of New Potentially Defective Alleles of Human Cyp2c9

Identification And Functional Characterization Of New Potentially Defective Alleles Of Human Cyp2c19

Identification and Functional Assessment of EightCYP3A4Allelic Variants39–46Detected in the Chinese Han Population

Identification And Functional Assessment Of A New Cyp2c9 Allelic Variant Cyp2c9(Star)59

Identification and drug metabolic characterization of four new CYP2C9 variants CYP2C972-75 in the Chinese Han population

Identification Of A Novel Variant Cyp2c9 Allele In Chinese

Identification and in vitro functional assessment of 10 CYP2C9 variants found in Chinese Han subjects

Deep mutational scanning of CYP2C19 in human cells reveals a substrate specificity-abundance tradeoff

CYP2C9 Allelic Variants: Ethnic Distribution and Functional Significance.

In Vitro and in Vivo Characterization of 13 CYP2C9 Allelic Variants Found in Chinese Han Population

Polymorphisms of Human Cytochrome P450 2c9 and the Functional Relevance

Genetic Polymorphism of the Human Cytochrome P450 2C9 Gene and Its Clinical Significance.

A Familial Study of Cytochrome P450 2D6(CYP2D6) Deficient Alleles

Genetic Polymorphisms And In Silico Mutagenesis Analyses Of Cyp2c9, Cyp2d6, And Cypor Genes In The Pakistani Population

In Vitro Functional Characterization of 37 CYP2C9 Allelic Isoforms Found in Chinese Han Population.

Cloning of CYP2J2 Gene and Identification of Functional Polymorphisms

Identification of CYP2D6 Impaired Functional Alleles in Mexican Americans.

Discovery and Enzyme Kinetic Characterization of Novel CYP2D6 Variants

Accuracy and applications of sequencing and genotyping approaches for CYP2A6 and homologous genes

Identification of Novel CYP2D7-2D6 Hybrids: Non-Functional and Functional Variants

Cytochrome P450 2C9 (CYP2C9) Polymorphisms in Chinese Li Population.